The cause of Parkinson's disease remains a mystery, but new research points to a protein that could stop the build up of Lewy bodies in the brain.

New research on alpha-synuclein fibrils in the brains of mice could eventually lead to new Parkinson's disease treatments.

Rapamycin is getting a lot of attention for its potential as an anti-aging drug. Now researchers have figured out exactly how it works.

Brain scans show differences between patients with Parkinson's disease who are on and off their meds and healthy people.

Research with mice shows how sensory and motor signals have different paths and effects on our behavior, which could lead to Parkinson's treatments.

New research confirms a connection between an REM sleep disorder and Parkinson's disease.

A new study breaks down how maganese exposure puts welders and others at a higher risk of developing Parkinson's disease-like symptoms.

A generic HIV drug shows promise for reducing age-related inflammation in mice. Could it treat Alzheimer's disease?

After injury or damage, nerve axons can kickstart their own self-destruction. A new gene therapy stops that process in mice.

A molecule that builds up in people with diseases like multiple sclerosis and Parkinson's disease may lead to ways to test for the disease earlier.